TrialVaccine2022

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.

Anh Duc Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.